// App-Quantinova.ai

: Forced vital capacity (FVC) decline in idiopathic pulmonary fibrosis (IPF) – modelling the myth

Researchers

Presenter

  • Marlies Wijsenbeek

Principal Investigators

  • Eva Santermans

  • Paul Ford

  • Michael Kreuter

  • Nadia Verbruggen

  • Paul Meyvisch

  • Wim Wuyts

  • Kevin Brown

  • David Lederer

  • Toby Maher

Medical Centers

  • Department of Internal Medicine, Erasmus University Medical Centre Rotterdam, Rotterdam, Netherlands

  • Galapagos, Mechelen, Belgium

  • Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg and German Center for Lung Research, Heidelberg, Germany

  • Unit for Interstitial Lung Diseases, Department of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium,

  • Department of Medicine, National Jewish Health, Denver, CO, United States,

  • Columbia University Irving Medical Center, New York, NY, United States of America

  • NIHR Respiratory Clinical Research Facility, Royal Brompton Hospital, London, United Kingdom,

Locations

  • Netherlands

  • Belgium

  • Germany

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved